Literature DB >> 2153917

Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation.

M Kaleko1, W J Rutter, A D Miller.   

Abstract

The human insulinlike growth factor I receptor was overexpressed in NIH 3T3 cells as well as human and rat primary fibroblast strains. The NIH 3T3 cells displayed a ligand-dependent, highly transformed phenotype. When exposed to insulinlike growth factor I or supraphysiologic levels of insulin, NIH 3T3 cells that expressed high levels of receptors formed aggregates in tissue culture dishes, colonies in soft agar, and tumors in nude mice. Expression of 1 million receptors per cell, a 40-fold increase above the base-line level, was required for anchorage-independent growth. Primary fibroblasts that expressed high levels of receptors displayed a ligand-dependent change in morphology and an increase in saturation density but did not acquire a fully transformed phenotype. The results demonstrate that when amplified, this ubiquitous growth factor receptor behaves like an oncogenic protein and is capable of promoting neoplastic growth in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153917      PMCID: PMC360815          DOI: 10.1128/mcb.10.2.464-473.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.

Authors:  M A Bender; T D Palmer; R E Gelinas; A D Miller
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

2.  An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.

Authors:  R G Elgin; W H Busby; D R Clemmons
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

3.  Hormonal regulation of human growth.

Authors:  M M Rechler; S P Nissley; J Roth
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

4.  Monensin blocks the maturation of receptors for insulin and somatomedin C: identification of receptor precursors.

Authors:  S Jacobs; F C Kull; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

Review 5.  Growth regulation of human breast carcinoma occurs through regulated growth factor secretion.

Authors:  M E Lippman; R B Dickson; E P Gelmann; N Rosen; C Knabbe; S Bates; D Bronzert; K Huff; A Kasid
Journal:  J Cell Biochem       Date:  1987-09       Impact factor: 4.429

6.  Activation of transforming potential of the human insulin receptor gene.

Authors:  L H Wang; B Lin; S M Jong; D Dixon; L Ellis; R A Roth; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).

Authors:  M F Roussel; T J Dull; C W Rettenmier; P Ralph; A Ullrich; C J Sherr
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

8.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

Authors:  T J Velu; L Beguinot; W C Vass; M C Willingham; G T Merlino; I Pastan; D R Lowy
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

9.  Heterogeneity of insulin-like growth factor-I affinity for the insulin-like growth factor-II receptor: comparison of natural, synthetic and recombinant DNA-derived insulin-like growth factor-I.

Authors:  R G Rosenfeld; C A Conover; D Hodges; P D Lee; P Misra; R L Hintz; C H Li
Journal:  Biochem Biophys Res Commun       Date:  1987-02-27       Impact factor: 3.575

10.  Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.

Authors:  A Ullrich; A Gray; A W Tam; T Yang-Feng; M Tsubokawa; C Collins; W Henzel; T Le Bon; S Kathuria; E Chen
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  91 in total

Review 1.  IGF and insulin action in the mammary gland: lessons from transgenic and knockout models.

Authors:  D L Hadsell; S G Bonnette
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

2.  Ethanol, Zn2+ and insulin interact as progression factors to enhance DNA synthesis synergistically in the presence of Ca2+ and other cell cycle initiators in fibroblasts.

Authors:  J S Huang; Q B She; K S Crilly; Z Kiss
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

3.  Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies.

Authors:  Amit Mahipal; Dave Shibata; Erin Siegel; Gregory Springett; Khaldoun Almhanna; William Fulp; Irene Williams-Elson; Richard Kim
Journal:  Invest New Drugs       Date:  2015-08-16       Impact factor: 3.850

Review 4.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

5.  The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.

Authors:  Matthew J Martin; Nataliya Melnyk; Michelle Pollard; Mary Bowden; Hon Leong; Thomas J Podor; Martin Gleave; Poul H B Sorensen
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

6.  Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor.

Authors:  K Akhilender Naidu; Richard C Karl; Kamatham A Naidu; Domenico Coppola
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

7.  Association of insulin receptor substrate 1 with simian virus 40 large T antigen.

Authors:  Z L Fei; C D'Ambrosio; S Li; E Surmacz; R Baserga
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

8.  Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.

Authors:  E Buchdunger; J Zimmermann; H Mett; T Meyer; M Müller; U Regenass; N B Lydon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 9.  IGF-I receptor, cell-cell adhesion, tumour development and progression.

Authors:  Loredana Mauro; Eva Surmacz
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

10.  Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts.

Authors:  C Sell; G Dumenil; C Deveaud; M Miura; D Coppola; T DeAngelis; R Rubin; A Efstratiadis; R Baserga
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.